Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma. - Shimauchi T; Murai J; Iwasaki M; Phadungsaksawasdi P; Ojima T; Fujii K; Honda T (NAR cancer, 2025)